Join to access to all OVN content. Join for Free

Results for 'cancer research'

The Long Game of Cancer Genomics: John Carpten, Ph.D., on Building Precision Oncology that Reaches Patients
Partner Avatar Monty Pal
The Long Game of Cancer Genomics: John Carpten, Ph.D., on Building Precision Oncology that Reaches Patients

City of Hope, Monty Pal, John Carpten, genomics, genome mapping, TGen, Translational Genomics Research Institute, spatial biology, AI, access

In this episode of On the Edge of Breakthrough: Voices of Cancer Research, John Carpten, Ph.D., Chief Scientific Officer at City of Hope, discusses the evolution of cancer genomics—how early genome mapping enabled today’s targeted approaches and what infrastructure and equity considerations will…

Mar 23rd • 56 mins listen

Pushing the Limits of Cancer Research and Surgery
Partner Avatar Monty Pal
Pushing the Limits of Cancer Research and Surgery

City of Hope, Monty Pal, Mustafa Raoof, PIPAC, peritoneal, pancreatic cancer, surgical oncology

Dr. Mustafa Raoof on PIPAC, pancreatic cancer research, and how global innovation can shape the next chapter of surgical oncology.

Apr 7th • 38 mins listen

Building the First AI Agent for Cancer Research
Partner Avatar Monty Pal
Building the First AI Agent for Cancer Research

City of Hope, Monty Pal, Enrique Velazquez Villarreal, Latino, colorectal cancer, mentor, genomics, AI, artificial intelligence, multiomic

Dr. Enrique Velazquez Villarreal on AI, genomics, and why young Latinos are at the heart of his work to improve colorectal cancer research and care.

May 5th • 49 mins listen

Expanding the Reach of TIL Therapy: What Will it Take?
Partner Avatar Monty Pal
Expanding the Reach of TIL Therapy: What Will it Take?

City of Hope, Monty Pal, Kelly Mahuron, TIL, tumor-infiltrating lymphocyte, melanoma, oncolytic virus, pancreatic cancer, colorectal tumor, immunotherapyn

Dr. Mahuron shares how tumor-infiltrating lymphocyte (TIL) therapy is evolving to reach more patients and improve cancer outcomes.

Aug 4th • 38 mins listen

How Team Science is Driving Lung Cancer Breakthroughs
Partner Avatar Monty Pal
How Team Science is Driving Lung Cancer Breakthroughs

City of Hope, Monty Pal, Loretta Erhunmwunsee, lung cancer, thoracic surgeon, air pollution, diversity

Dr. Loretta Erhunmwunsee explores her latest groundbreaking research investigating the impact of air pollution on lung cancer and shares how team science is critical to advancing cancer care for all.

Aug 19th • 32 mins listen

Why Genetic Testing Should Be Standard in Prostate Cancer
Partner Avatar Rebecca Previs
Why Genetic Testing Should Be Standard in Prostate Cancer

Labcorp, Rebecca Previs, Sarah Young, genetic counselor, genetic testing, prostate cancer, urologic oncology, germline, somatic, PARP inhibitors, digital

Hear why universal genetic testing matters in prostate cancer — plus, how it can improve treatment, equity, and outcomes for patients everywhere.

May 18th • 19 mins listen

Redefining Ovarian Cancer Care with Biomarkers
Partner Avatar Rebecca Previs
Redefining Ovarian Cancer Care with Biomarkers

Labcorp, Rebecca Previs, Kyle Strickland, ovarian cancer, diagnosis, biomarker, HRD, RB1, tumor biology

Exploring ovarian cancer, biomarkers HRD & RB1, and how Labcorp innovations are advancing precision oncology.

Sep 7th • 14 mins listen

FFPE: The Workhorse Behind NGS Testing
Partner Avatar Rebecca Previs
FFPE: The Workhorse Behind NGS Testing

Labcorp, Rebecca Previs, Kyle Strickland, Erin Newburn, biomarker, sequencing, diagnostics, translational research, precision

Exploring FFPE’s impact on precision oncology, NGS innovation, and the future of tissue stewardship in cancer care with leading Labcorp experts.

Jan 28th • 33 mins listen

How Cross-Functional Teams Reshape Cancer Care
OVN Avatar Kirk Shepard
How Cross-Functional Teams Reshape Cancer Care

Jay Fine, Preclinical Research, Early Stage

In episode 3 of Oncology Voice Network Podcast, Dr. Kirk Shepard sits down with Dr. Jay Fine, a renowned immunologist and President of R&D at Evolve Immune Therapeutics and a Forbes-published author in Voices of Oncology, for a candid look at how discovery truly connects to patient care.

Feb 17th • 23 mins listen

The Authority Company | Breaking Silos in Oncology
OVN Avatar OVN Staff
The Authority Company | Breaking Silos in Oncology

oncologyinnovation, cancercare, biotechleadership, pharmacommunity, oncologyresearch, collaborationinscience, lifesciences, patientimpact, healthinnovation, oncologyvoicenetwork

In this episode of The Authority Company Podcast, host Joe Pardavila sits down with Dr. Ramin Farhood and Dr. Kirk Shepard, co-authors of Voices of Oncology and co-founders of the Medical Affairs Professional Society (MAPS). Together, they share how breaking down silos, fostering collaboration, and …

Oct 26th • 30 mins listen

Unlocking the Future of Cancer Care: Precision Medicine, AI and the Patient Voice with Dr. Stacy Gray
Partner Avatar Monty Pal
Unlocking the Future of Cancer Care: Precision Medicine, AI and the Patient Voice with Dr. Stacy Gray

City of Hope, Monty Pal, Stacy Gray, precision medicine, germline testing, INSPIRE program, whole body MRI, genomic, tumor board

In this episode of On the Edge of Breakthrough: Voices of Cancer Research, Stacy Gray, M.D., A.M., Director of Clinical and Scientific Strategy and Vice President of System Strategy at City of Hope, joins Monty Pal, M.D., F.A.S.C.O. in an engaging discussion of how precision medicine and AI are tran…

Feb 23rd • 43 mins listen

Enhancing Cancer Treatment Decisions with Ultrasensitive MRD Testing
Partner Avatar Jesus Izaguirre-Carbonell
Enhancing Cancer Treatment Decisions with Ultrasensitive MRD Testing

Quest Diagnostics, Jesus Izaguirre Carbonell, Thoman Slavin, MRD testing, minimal residual testing, precision tool, biomarker, ctDNA, circulating tumor DNA

Dr. Thomas Slavin breaks down how ultrasensitive MRD testing supports better cancer treatment decisions and enables earlier, more personalized interventions.

Jul 7th • 19 mins listen

Advancing Cancer Survivorship and Cardio-Oncology
Partner Avatar Monty Pal
Advancing Cancer Survivorship and Cardio-Oncology

City of Hope, Monty Pal, Saro Armenian, pediatric, cardio-oncology, CHIP clinic

Dr. Saro Armenian discusses breakthroughs in cancer survivorship, pediatric oncology and City of Hope’s pioneering work in cardio-oncology.

Feb 24th • 39 mins listen

The Future of Cancer Surgery: Innovations, AI, and Remote Robotics
Partner Avatar Monty Pal
The Future of Cancer Surgery: Innovations, AI, and Remote Robotics

City of Hope, Monty Pal, Yuman Fong, AI, robotics, surgical oncology, oncolytic virus, remote surgical procedure

Dr. Yuman Fong shares insights on AI, robotics, the future of surgical oncology, plus his groundbreaking work in oncolytic viruses and the importance of mentorship.

Mar 10th • 33 mins listen

Breaking Barriers in Cancer Care: Expanding Access, Innovation & Integrative Medicine
Partner Avatar Monty Pal
Breaking Barriers in Cancer Care: Expanding Access, Innovation & Integrative Medicine

City of Hope, Monty Pal, Edward Kim, integrative oncology, national clinical trial, patient access

Dr. Ed Kim shares insights on why redefining the standard of care is critical for improving patient outcomes, the future of clinical trials, and the role of integrative medicine in oncology.

Mar 21st • 33 mins listen

Humanizing Cancer Treatment Through Whole-Person Care
Partner Avatar Monty Pal
Humanizing Cancer Treatment Through Whole-Person Care

City of Hope, Monty Pal, Betty Ferrell, palliative care, quality of life, pain management, bone marrow transplantation, Ethiopia

Dr. Betty Ferrell on her global legacy in palliative care and why whole-person treatment is as crucial as fighting cancer itself.

Apr 21st • 47 mins listen

Three Leaders, One Vision: Principles for Transforming Cancer Care Delivery
Partner Avatar Monty Pal
Three Leaders, One Vision: Principles for Transforming Cancer Care Delivery

City of Hope, Monty Pal, Walter Stadler, Alan Bryce, ASCO, national model, precision, AI, clinical trial design, dose strategy, early detection, long term survivorship

Dr. Walter Stadler & Dr. Alan Bryce share how City of Hope is building a national system for smarter research, greater access, and better cancer care.

Jun 23rd • 43 mins listen

At the Crossroads of Cancer and Metabolism
Partner Avatar Monty Pal
At the Crossroads of Cancer and Metabolism

City of Hope, Monty Pal, Charles Brenner, metabolism, diabetes, obesity, fatty liver, metabolic dysfunction, GLP-1, FGF21, NAD metabolism

Dr. Charles Brenner explores the metabolic links between cancer, diabetes, NAD, and the future of liver-focused therapies.

Jul 7th • 37 mins listen

How Team Science Fuels Cancer Breakthroughs: A Conversation with Dr. Marcel van den Brink
Partner Avatar Monty Pal
How Team Science Fuels Cancer Breakthroughs: A Conversation with Dr. Marcel van den Brink

KOL, City of Hope, Marcel van den Brink, Monty Pal, T cell, thymus, immune recovery, microbiome, transplant outcomes

In the season 4 premiere of On the Edge of Breakthrough: Voices of Cancer Research, Monty Pal, M.D., F.A.S.C.O., welcomes Marcel van den Brink, M.D., Ph.D., President of City of Hope Los Angeles and City of Hope National Medical Center, Chief Physician Executive and the Deana and Steve Campbell Phys…

Feb 10th • 57 mins listen

How to Accelerate Cancer Cures Through Collaboration with Kirk V. Shepard, MD
Partner Avatar Michael Pietrack
How to Accelerate Cancer Cures Through Collaboration with Kirk V. Shepard, MD

Kirk Shepard, Michael Pietrack, mentor, AI, digital

Join host Michael Pietrack on the PharmaVerse Podcast as he speaks with Dr. Kirk Shepard, Chief Medical Officer of PDS Biotechnology, co-founder of the Medical Affairs Professional Society (MAPS), and creator of the Oncology Voices Network (OVN).

Feb 2nd • 24 mins listen

Related Topics

Meet Our Innovation Partners

Loading partners...